dMY Technology Dette/Equité
Quel est le Dette/Equité de dMY Technology?
Le Dette/Equité de dMY Technology Group, Inc. est 2.02
Quelle est la définition de Dette/Equité?
Le ratio d'endettement et d'équité est un ratio financier indiquant la proportion relative des capitaux propres et de la dette utilisée pour financer les actifs d'une entreprise.
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Dette/Equité des entreprises dans Finance secteur sur NYSE par rapport à dMY Technology
Que fait dMY Technology?
dMY Technology Group, Inc. focuses to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. the company was founded in 2019 and is based in Las Vegas, Nevada.
Entreprises avec dette/equité similaire à dMY Technology
- Red Electrica Eo ,50 a Dette/Equité de 2.02
- Red Eléctrica SA a Dette/Equité de 2.02
- Encavis AG a Dette/Equité de 2.02
- Charles Stanley Plc a Dette/Equité de 2.02
- Li & Fung a Dette/Equité de 2.02
- CAR a Dette/Equité de 2.02
- dMY Technology a Dette/Equité de 2.02
- Delta Apparel a Dette/Equité de 2.02
- Colabor a Dette/Equité de 2.02
- Varian Medical Systems a Dette/Equité de 2.02
- Triveni Engineering & Industries a Dette/Equité de 2.02
- Hindustan Aeronautics a Dette/Equité de 2.02
- Taiwan Liposome a Dette/Equité de 2.02